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his journal’s editors have asked me to com-
ment on the paper in this issue by Jetton et al.
entitled "Substrate induced nuclear export and
peripheral compartmentalization of hepatic
glucokinase correlates with glycogen deposition." The
investigations of these authors exemplify the remarkable
recent trend in studies of intermediary metabolism paying
careful attention to the precise intracellular location of
biochemical processes including also those that are con-
ventionally assumed to occur in the aequeous cytoplasmic
compartment. The investigative history of the glucokinase
enzymemthe topic of the paper editorialized heremstrik-
ingly illustrates the slow pace of evolution in studies of
this particular aspect of intermediary metabolism, starting
perhaps with the pioneering concepts of Paul Srere in the
sixties [1].
Glucokinase was long considered a typical soluble
cytosolic enzyme. Sidney Weinhouse and Alberto Sols dis-
covered the enzyme in the high speed supernatant of liver
extracts with negligible residue in the particulate fraction
[2,3]. This distribution contrasted with that of glucose-6-
phosphatase which was associated with the microsomes.
A striking intraacinar gradient of glucokinase exhibiting
significantly higher activities in the pericentral as com-
pared to the peripheral zones was discovered in the late
seventies [4]. It is of interest that glucose-6-phospahatase
has an intraacinar gradient opposite to that of glucoki-
nase. The kinetic characteristics of the enzyme, its S0.5 of
about 8.0 mM, ATP Km of about 0.3 mM and Hill coef-
ficient of about 1.7 explained its optimal operation in the
aequeous cytosolic compartment of hepatocytes where
physiological glucose levels of 5 to 8 mM approximate
those of plasma and ATP2-, the second substrate, is about
2.5 mM [5]. Consequently, a soluble glucokinase could
operate close to its inflection point of about 4.0 mM
where it is most responsive to changes of glucose levels.
Since the enzyme is not directly controlled by glucose-6-
phosphate as feedback inhibitormmore about this laterm
regulation of its activity was initially thought to be pri-
marily due to alteration of protein synthesis stimulated by
insulin. After glucokinase was discovered in pancreatic
islets the conceptualization of the enzyme as cytoplasmic
beta-cell glucose sensor followed the general outline of its
biochemistry in hepatocytes except that its expression was
considered to be controlled directly by glucose rather than
by insulin [5].
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FIGURE
MOLECULAR BASIS OF THE INTRACELLULAR EBB AND TIDE OF GLUCOKINASE
The nuclear and cytosolic compartments, nuclear membrane pores and cell membrane associated GK binding sites are sketched. Three
interconvertable GK forms are postulated to exist (i.e. GK, GK1, and GK depicted by distinct ikons). They are in equilibrium and GK pre-
dominates in the basal state. This equilibrium is shifted by glucose, pharmacological (and putative endogenous) GK activators and by
GKRE F6P and F1P influence the equilibrium between a GK inhibitory form (GKRP) and non inhibitory form (GKRP1) of the nuclear
protein. Nuclear and cytosolic GK and GK are in equilibrium and are able to traverse the nuclear membrane through its pores. Structural
elements associated with the cell membrane sequester GK and GK via specific bnding sites which are exposed by glucose or GK activa-
tor binding.
The "classic picture," as briefly outlined above, has
been replaced step by step by a dynamic "modern view"
in which subcellular compartmentation and allosteric reg-
ulation add a higher level of complexity and the possibil-
ity of control on a time scale of seconds to minutes. This
development is greeted with a sense of excitement in this
sector of metabolic regulation research. The present
report by Jetton et al. has to be read with such a mind set.
A few historical and prospective comments about these
recent discoveries may aid in the understanding of this
important topic. The seminal discovery of the glucokinase
regulatory protein (GKRP) in the late 1980s by van
Schaftingen got the ball rolling. GKRP is a 68.5 KD pro-
tein that inhibits glucokinase competitively with glucose
[6]. Its efficacy is increased by fructose-6-phosphate (F6P)
and diminished by fructose-I-phosphate (FIP) explaining
the physiologically and potentially therapeutic relevant
activation of glucose metabolism by fructose. It is note-
worthy that GKRP regulation of glucokinase does not
seem to be a factor in pancreatic beta-cell glucose metab-
olism. The work of Agius, Miwa, Mookhtiar and Toyoda
opened an entirely new dimension by. demonstrating the.
nuclear localization of GKRP and its role in glucokinase
redistribution between nuclear and cytosolic compart-
ments, the nutrient regulated intracellular "ebb and tide"
of glucokinase [7,8]. The newest extension of this dynam-
ic view is seen in the present and related publications
demonstrating quite convincingly that glucokinase associ-
ates reversibly with the glycogen synthesis apparatus as it
initiates the postprandial process of glucose polymeriza-
tion at sites close to the cell membrane of the hepatocyte.
Recent observations suggesting an association of glu-
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cokinase with the insulin containing secretory.granules
are relevant in this context [9]. Evidence for glucose
responsive circumscribed polar sequestration of beta cell
glucokinase was first reported by Bonner-Weir and her
group and the number of publications confirming and
extending these earlier observations has steadily grown
increasing the weight of the evidence. A physiological
role, if any, for insulin granule associated glucokinase has,
however, not been established or conceptualized.
The nutrient dependent subcellular compartmentation
and dynamic ebb and tide of glucokinase in hepatocytes
(and possibly pancreatic beta-cells) has profound implica-
tions for the biochemistry and molecular pathology of this
enzyme and entices the writer of this editorial to sketch a
minimal working model of this particular aspect of glu-
cokinase regulation (Figure 1). Central to this model are
the ligand induced slow transition (LIST) of glucokinase
structure due to conformational changes of the enzyme as
first demonstrated by Kenneth Neet [10] and the existence
of multiple allosteric regulatory sites which interact with
activators, inhibitors and cellular matrix proteins, many
of them hypothetical at this juncture. Glucose is the prime
mover in this model and fructose serves as physiological-
ly significant indirect modifier via F1P, consistent with the
data (see, for ekample, Figure 1 of Jetton’s paper). An
allosteric activator site for a putative endogenous stimula-
tor is postulated by extrapolating from recent reports of
activating mutations found in patients with persistent
hyperinsulinemic hypoglycemia in infancy (PHHi) and
from successful pharmacological activation of glucoki-
nase [11,12]. Glucose generates the activated GK form
which dissociates from the GKRP/GK complex and is able
to exit through nuclear pores possibly by involving spe-
cific recognition sequences of the enzyme. GK has also
increased affinity for matrix ankers close to the cell mem-
brane (e.g. actin filaments or other ultramicroscopic struc-
tures). It is also speculated here that the binding might
enhance the specific activity and increase the glucose
affinity of the enzyme. GK1, now positioned strategically,
generates glucose-6-phosphate (G6P) locally enhancing
the efficacy of the cell membrane associated glycogen
apparatus. Fructose via FIP dissociates the GKRP/GK
complex by generating GKRP and GK is able to exit
through nuclear pores. By mass action GK in the cytosol
increases and hence the binding of GK to the glycogen
synthesis apparatus is enhanced even at relatively low glu-
cose. Lowering the cellular fructose or glucose reverses the
process. The new class of allosteric activators (GKAs)
facilitates the production of G6P by inducing the activat-
ed GK form which may or may not be matrix bound. It
is conceivable that these activators could counteract F6P
dependent GKRP inhibition of GK in the nucleus, enhance
dissociation of the GKRP/GK complex and elevate
nuclear and cytosolic GK levels (this aspect is not illus-
trated in the diagram).
The biological significance of GKRP’s role and the
sketch drawn here are mitigated somewhat by the out-
come of studies with GKRP knockout mice [13].
Surprisingly, these animals are phenotypically normal.
Most importantly, there seems to be no gross defect of
glucose homeostasis, even though nuclear GK sequestra-
tion is abrogated and total GK content of hepatocytes is
reduced by ca 50%. It will be illuminating to use these
knockout mice in studies similar to those presented here
by Jetton et al. to study intracellular GK redistribution
during fructose and glucose loads in the absence of
GKRP. Does the movement of GK to the cell membrane
depend on nuclear GKRP? The model predicts that it
would not. One should not forget however that, viewed in
isolation, studies with gene knockout animals might be
misleading.
This simple model could explain the currently pub-
lished liver data. It implies that activated GK has new
binding sites exposed allowing the attachment of the
enzyme to cellular matrix components. It also implies the
possibility of point mutations of GK that might specifical-
ly interfere with this process and might be a cause of
MODY-2 or even permanent neonatal diabetes mellitus
(PNDM) [14]. It is noteworthy in this context that the
diabetggenic effect of certain GK mutations in MODY-2
remains unexplained. The model raises the possibility of
impaired or enhanced intracellular GK redistribution
which might be caused by pathological changes of the
components that participate in this process but would not
be GK linked, i.e. are possible candidates for MODY-X.
The full characterization of GK missense mutations caus-
ing PHHI, MODY-2 and PNDM will therefore require the
assessment of sequences that must be postulated to govern
enzyme compartmentation. Incidently, much of what has
been discussed here may also pertain to the pancreatic
beta-cell, with modifications, of course, because GKRP is
probably absent.
Certain spontaneous and man made mutants of GK
may represent the fully activated state depicted here as
GK [11]. They have a kcat of as much as 1.5 times nor-
mal, a glucose So.5 of 1.0 to 2.5 mM instead of 8.5 mM
and lower Hill coefficients (a measure of the cooperativi-
ty with glucose). It is conceivable that mutant induced
changes of the enzyme influence its subcellular distribu-
tion that occurs physiologically. It seems plausible to pre-
dict that certain activated GK forms would enhance
translocation to the cell membrane. Individuals with such
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mutations (i.e. V455M) maintain significant glycogen
stores in the face of low bloodsugar of about 2.5 mM as
shown by the results of glucagon challenges. GK activat-
ed by allosteric mutants offers a unique opportunity for
studying the biochemistry of intracellular movements of
enzyme.
These are just a few of the implications of the modern-
ized view of GK biochemistry as exemplified by the paper
of Jetton et al. It can be expected that the continued pur-
suit of research focusing on the dynamics of intracellular
hepatic (or beta-cell) GK distribution as influenced by
nutritional, pharmacological and genetic factors will
greatly expand our understanding of glucose homeostasis
in health and will assist in the therapeutic management of
diabetes mellitus and related disorders.
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